Abstract:IMPORTANCE Early breast development is a risk factor for breast cancer, and girls with a breast cancer family history (BCFH) experience breast development earlier than girls without a BCFH. OBJECTIVES To assess whether prepubertal androgen concentrations are associated with timing of breast development (analysis 1) and to compare serum androgen concentrations in girls with and without a BCFH (analysis 2). DESIGN, SETTING, AND PARTICIPANTS Prospective cohort study of 104 girls aged 6 to 13 years at baseline using data collected between August 16, 2011, and March 24, 2016, from the Lessons in Epidemiology and Genetics of Adult Cancer From Youth (LEGACY) Girls Study, New York site. EXPOSURES Analysis 1 included serum concentrations of dehydroepiandrosterone sulfate, androstenedione, and testosterone (free and total) measured before breast development and divided at the median into high and low categories. Analysis 2 included the degree of BCFH: first-degree was defined as having a mother with breast cancer and second-degree was defined as having a grandmother or aunt with breast cancer. MAIN OUTCOMES AND MEASURES Analysis 1 included age at onset of breast development measured using the Pubertal Development Scale (scores range from 1-4; scores >= 2 indicate breast development), and analysis 2 included serum androgen concentrations. We also assessed breast cancer-specific distress using the 8-item Child Impact of Events Scale. RESULTS Our analyses included 36 girls for the prospective model, 92 girls for the cross-sectional model, and 104 girls for the longitudinal model. Of the 104 girls, the mean (SD) age at baseline was 10.3 (2.5) years, and 41 (39.4%) were non-Hispanic white, 41 (39.4%) were Hispanic, 13 (12.5%) were non-Hispanic black, and 9 (8.7%) were other race/ethnicity. Forty-two girls (40.4%) had a positive BCFH. Girls with prepubertal androstenedione concentrations above the median began breast development 1.5 years earlier than girls with concentrations below the median (Weibull survival model-estimated median age, 9.4 [95% CI, 9.0-9.8] years vs 10.9 [95% CI, 10.4-11.5] years; P =.001). Similar patterns were observed for dehydroepiandrosterone sulfate (1.1 years earlier: age, 9.6 [95% CI, 9.1-10.1] years vs 10.7 [95% CI, 10.2-11.3] years; P =.009), total testosterone (1.4 years earlier: age, 9.5 [95% CI, 9.1-9.9] years vs 10.9 [95% CI, 10.4-11.5] years; P =.001), and free testosterone (1.1 years earlier: age, 9.7 [95% CI, 9.2-10.1] years vs 10.8 [95% CI, 10.2-11.4] years; P =.01). Compared with girls without BCFH, girls with a first-degree BCFH, but not a second-degree BCFH, had 240% higher androstenedione concentrations (geometric means: no BCFH, 0.49 ng/mL vs first-degree BCFH, 1.8 ng/mL vs second-degree, 1.6 ng/mL; P =.01), 10% higher total testosterone concentrations (12.7 ng/dL vs 14.0 ng/dL vs 13.7 ng/dL; P =.01), and 92% higher free testosterone concentrations (1.3 pg/mL vs 2.5 pg/mL vs 0.3 pg/mL; P =.14). The dehydroepiandrosterone sulfate concentration did not differ between BCFH-positive and BCFH-negative girls but was elevated in girls with breast cancer-specific distress. CONCLUSIONS AND RELEVANCE Our findings suggest that androgen concentrations may differ between girls with and without a BCFH and that elevated hormone concentrations during adolescence may be another factor to help explain the familial clustering of breast cancer.

Childhood growth and breast cancer

Associations Between Maternal Age at Menarche and Anthropometric and Metabolic Parameters in the Adolescent Offspring.

Pubertal timing and breast cancer risk in the Sister Study cohort

Association of the Age at Menarche with Site-Specific Cancer Risks in Pooled Data from Nine Cohorts

Adult Height is Associated with Increased Risk of Ovarian Cancer: a Mendelian Randomisation Study

Adult height and the risk of cause-specific death and vascular morbidity in 1 million people: individual participant meta-analysis

Body Mass Index Rebound and Pubertal Timing in Girls with and Without a Family History of Breast Cancer: the LEGACY Girls Study.

Associations of Weight Gain from Early to Middle Adulthood with Major Health Outcomes Later in Life.

Adult Height, Dietary Patterns, and Healthy Aging.

Association of Prepubertal and Adolescent Androgen Concentrations with Timing of Breast Development and Family History of Breast Cancer.

Weight, dietary behavior, and physical activity in childhood and adolescence: implications for adult cancer risk

Maternal and Prenatal Factors and Age at Thelarche in the LEGACY Girls Study Cohort: Implications for Breast Cancer Risk

Associations of early-life and adult anthropometric measures with the expression of stem cell markers CD44, CD24, and ALDH1A1 in women with benign breast biopsies

An International Ecological Study of Adult Height in Relation to Cancer Incidence for 24 Anatomical Sites

Risk of breast cancer in relation to anthropometry, blood pressure, blood lipids and glucose metabolism: a prospective study within the Malmö Preventive Project

Early Life Growth, Socioeconomic Status, and Mammographic Breast Density in an Urban US Birth Cohort.

Age at menarche in relation to adult height: the EPIC study

Abstract 18217: Adult Height, Lifestyle and Healthy Aging

Anthropometry and Female Breast Cancer: a Prospective Cohort Study in Urban Shanghai

Prospective Cohort Study of Body Height and Cancer Incidence among Adult Men and Women in Shanghai

Body Fatness At A Young Age, Body Fatness Gain And Risk Of Breast Cancer: Systematic Review And Meta-Analysis Of Cohort Studies